Brighton Jones LLC’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $336K | Sell |
1,032
-177
| -15% | -$57.7K | 0.01% | 672 |
|
|
2025
Q1 | $326K | Buy |
1,209
+177
| +17% | +$47.8K | 0.01% | 505 |
|
|
2024
Q4 | $243K | Buy |
+1,032
| New | +$243K | 0.01% | 588 |
|
|
2023
Q4 | – | Sell |
-3,912
| Closed | -$693K | – | 584 |
|
|
2023
Q3 | $693K | Buy |
3,912
+136
| +4% | +$24.1K | 0.04% | 230 |
|
|
2023
Q2 | $717K | Buy |
3,776
+23
| +0.6% | +$4.37K | 0.04% | 239 |
|
|
2023
Q1 | $752K | Buy |
+3,753
| New | +$752K | 0.04% | 218 |
|
|
2018
Q3 | – | Sell |
-3,957
| Closed | -$390K | – | 284 |
|
|
2018
Q2 | $390K | Sell |
3,957
-47
| -1% | -$4.63K | 0.05% | 200 |
|
|
2018
Q1 | $477K | Sell |
4,004
-18
| -0.4% | -$2.14K | 0.07% | 162 |
|
|
2017
Q4 | $511K | Buy |
4,022
+11
| +0.3% | +$1.4K | 0.06% | 149 |
|
|
2017
Q3 | $471K | Hold |
4,011
| – | – | 0.06% | 159 |
|
|
2017
Q2 | $320K | Buy |
+4,011
| New | +$320K | 0.05% | 189 |
|
|
2016
Q4 | – | Sell |
-3,919
| Closed | -$266K | – | 107 |
|
|
2016
Q3 | $266K | Buy |
+3,919
| New | +$266K | 0.04% | 194 |
|